| 1 |
Bromocriptine therapy: Review of mechanism of action, safety and tolerability |
|
| | Faiza Naz, Abdul Malik, Muhammad Riaz, Qaisar Mahmood, Malik Hassan Mehmood, Ghulam Rasool, Zahed Mahmood, Mazhar Abbas | | | Clinical and Experimental Pharmacology and Physiology. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases |
|
| | Alexander O Shpakov, Kira V Derkach, Lev M Berstein | | | Future Science OA. 2015; 1(3) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Di-peptidyl peptidase-4 inhibitor sitagliptin protects vascular function in metabolic syndrome: possible role of epigenetic regulation |
|
| | Cicek Figen Amber,Tokcaer-Keskin Zeynep,Ozcinar Evren,Bozkus Yusuf,Akcali Kamil Can,Turan Belma | | | Molecular Biology Reports. 2014; | | | [Pubmed] [Google Scholar] [DOI] | |
|
